Are there risks factors with respect to breast cancer from taking bio-identical hormones?
For medicolegal purposes we have to assume risk factors for bio-identical hormone replacement are similar to those associated to using synthetic HRT. However there are some studies suggesting bio-identical oestriol which is used as the majority of the oestrogen in troches is perhaps safer than synthetic oestrogen. This combined with blood testing to ensure the minimum amount of oestrogen is used to control symptoms would perhaps confer an increased level of safety when using bio-identical hormone replacement. Further studies are probably necessary to confirm the above information.
